These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 482317)

  • 21. On the interaction of drugs with the cholinergic nervous system--IV. Tolerance to oxotremorine in mice: in vivo and in vitro studies.
    Maayani S; Egozi Y; Pinchasi I; Sokolovsky M
    Biochem Pharmacol; 1977 Sep; 26(18):1681-7. PubMed ID: 901587
    [No Abstract]   [Full Text] [Related]  

  • 22. [General pharmacology and secretion inhibitory action of (8r)-3alpha-hydroxy-8-isopropyl-1alphaH,5alphaH-tropanium bromide-(+/-)-tropate (ipratropiumbromide) (author's transl)].
    Bauer R; Kuhn FJ; Stockhaus K; Wick H
    Arzneimittelforschung; 1976; 26(5a):974-80. PubMed ID: 134727
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stereoselectivity of some oxotremorine antagonists containing two chiral centres.
    Ringdahl B; Resul B; Dahlbom R
    J Pharm Pharmacol; 1979 Dec; 31(12):837-9. PubMed ID: 43369
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Abolition of oxotremorine effects by L-DOPA pretreatment.
    Korczyn AD; Eshel Y
    Neuropharmacology; 1979 Jul; 18(7):601-3. PubMed ID: 573869
    [No Abstract]   [Full Text] [Related]  

  • 25. The effect of elantrine, a new anti-Parkinsonism agent, on drug-induced tremor in mice.
    Ursillo RC; McCulloch JA
    Arch Int Pharmacodyn Ther; 1972 May; 197(1):132-40. PubMed ID: 5031571
    [No Abstract]   [Full Text] [Related]  

  • 26. Cholinergic activity of acetylenic imidazoles and related compounds.
    Moon MW; Chidester CG; Heier RF; Morris JK; Collins RJ; Russell RR; Francis JW; Sage GP; Sethy VH
    J Med Chem; 1991 Aug; 34(8):2314-27. PubMed ID: 1875333
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Postnatal development of central effects of atropine and oxotremorine in dogs in relation to brain development.
    Windbladh B
    Acta Pharmacol Toxicol (Copenh); 1973; 32(1):65-82. PubMed ID: 4741040
    [No Abstract]   [Full Text] [Related]  

  • 28. Cholinolytic activity of 3-hydroxyquinuclidyl-1-phenyl-1-cyclohexyl-1-carboxylate hydrochloride (ANC-821).
    Jedrych Z
    Pol J Pharmacol Pharm; 1983; 35(2):103-7. PubMed ID: 6688667
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regional differences in receptor reserve for analogs of oxotremorine in vivo: implications for development of selective muscarinic agonists.
    Ringdahl B; Roch M; Jenden DJ
    J Pharmacol Exp Ther; 1987 Aug; 242(2):464-71. PubMed ID: 3612545
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic effects of some cholinolytics in organophosphate intoxications.
    Faff J; Borkowska G; Bak W
    Arch Toxicol; 1976 Oct; 36(2):139-46. PubMed ID: 1036888
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amygdala beta-noradrenergic influences on memory storage involve cholinergic activation.
    Introini-Collison IB; Dalmaz C; McGaugh JL
    Neurobiol Learn Mem; 1996 Jan; 65(1):57-64. PubMed ID: 8673407
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proceedings: On the action of oxotremorine on the cholinergic system of rat brain.
    Pleul O
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R75. PubMed ID: 4276628
    [No Abstract]   [Full Text] [Related]  

  • 33. Antagonism of aceclidine-induced tremor, analgesia, hypothermia, salivation and lacrimation by some pharmacologic agents.
    Chiang TS; Leaders FE
    Arch Int Pharmacodyn Ther; 1971 Feb; 189(2):295-305. PubMed ID: 5548767
    [No Abstract]   [Full Text] [Related]  

  • 34. Centrally active antimuscarinic analogs of oxotremorine selectively block physostigmine-induced hypertension, but not peripheral muscarinic vasodepression.
    Vargas HM; Ringdahl B
    J Pharmacol Exp Ther; 1990 Apr; 253(1):165-70. PubMed ID: 2329503
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alterations in behavioral responses to a cholinergic agonist in post-pubertal rats with neonatal ventral hippocampal lesions: relationship to changes in muscarinic receptor levels.
    Laplante F; Nakagawasai O; Srivastava LK; Quirion R
    Neuropsychopharmacology; 2005 Jun; 30(6):1076-87. PubMed ID: 15637638
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Some observations on the effects of enantiomers of two benzomorphan narcotic antagonists and atropine on analgesia, tremor and hypothermia produced by oxotremorine.
    Ben-Sreti MM; Sewell RD; Upton N
    Arch Int Pharmacodyn Ther; 1982 Apr; 256(2):219-27. PubMed ID: 7103612
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of peripheral catecholamines in oxotremorine tremor in the rat and its antagonism by beta adrenoceptor blocking agents.
    Weinstock M; Zavadil AP; Rosin AJ; Chiueh CC; Kopin IJ
    J Pharmacol Exp Ther; 1978 Jul; 206(1):91-6. PubMed ID: 26800
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The value of premedication in diminishing salivary secretions.
    Kamel M; Tewfik O; Ibrahim S
    Middle East J Anaesthesiol; 1975 Jun; 4(5):363-71. PubMed ID: 1243859
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interactions between oxotremorine and inhibitors of cholinesterase enzymes.
    Cox B; Tha SJ
    J Pharm Pharmacol; 1973 Jul; 25(7):544-9. PubMed ID: 4147051
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of AIT-082, a purine derivative, on tremor induced by arecoline or oxotremorine in mice.
    Nannan G; Runmei Y; Fusheng L; Shoulan Z; Guangqing L
    Pharmacology; 2007; 80(1):21-6. PubMed ID: 17496436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.